ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1
0/0

Tantalum Oxide Nanoparticles as Versatile Contrast Agents for X-ray Computed Tomography

preprint
submitted on 13.02.2020 and posted on 13.02.2020 by Shatadru Chakravarty, Jeremy Hix, Kaitlyn Wieweora, Maximilian Volk, Elizabeth Kenyon, Dorela D. Shuboni-Mulligan, Barbara Blanco-Fernandez, Matti Kiupel, Jennifer Thomas, Lorenzo F. Sempere, Erik Shapiro
Here we describe the synthesis, characterization and in vitro and in vivo performance of a series of tantalum oxide (TaOx) based nanoparticles (NPs) for computed tomography (CT). Five distinct versions of 9-12 nm diameter silane coated TaOx nanocrystals (NCs) were fabricated by a sol-gel method with varying degrees of hydrophilicity and with or without fluorescence, with the highest reported Ta content to date (78%). Highly hydrophilic NCs were left bare and were evaluated in vivo in mice for micro-CT of full body vasculature, where following intravenous injection, TaOx NCs demonstrate high CT contrast, circulation in blood for ~ 3 h, and eventual accumulation in RES organs; and following injection locally in the mammary gland, where the full ductal tree structure can be clearly delineated. Partially hydrophilic NCs were encapsulated within mesoporous silica nanoparticles (MSNPs; TaOx@MSNPs) and hydrophobic NCs were encapsulated within poly(lactic-co-glycolic acid) (PLGA; TaOx@PLGA) NPs, serving as potential CT-imagable drug delivery vehicles. Bolus intramuscular injections of TaOx@PLGA NPs and TaOx@MSNPs to mimic the accumulation of NPs at a tumor site produce high signal enhancement in mice. In vitro studies on bare NCs and formuated NPs demonstrate high cytocompatibility and low dissolution of TaOx. This work solidifies that TaOx-based NPs are versatile contrast agents for CT.

Funding

MSU Foundation Strategic Partnership Grant

NIH R21 CA185163

NIH R21 EB017881

NIH R21 CA226579

History

Email Address of Submitting Author

shapir86@msu.edu

Institution

Michigan State University

Country

United States

ORCID For Submitting Author

0000-0002-0901-5781

Declaration of Conflict of Interest

No conflict of interest

Exports